SAbR | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

554 results for “SAbR”

Trials

View all 306 →

SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients

First posted Apr 24, 2017

Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma

7 participants · First posted May 24, 2016

Prostate SABR With Intra-Prostatic SABR Boost

30 participants · First posted Dec 27, 2019

Drugs

View all 164 →

Vigabatrin(Sabril, Vigadrone, Kigabeq)

Conditions: Infantile Spasms (IS), Refractory Complex partial seizures

C₆H₁₁NO₂ · Rx

SABA (Pulmatrix)

CD19 CAR-T-Sabz (Sabz Biomedicals)

Organizations

Sabz Biomedicals

Dare Bioscience

United States

SAB Biotherapeutics

United States

News

View all 81 →

SABR Shows Promise in Renal Cell Carcinoma Management

Surgery Shows Superior Outcomes Over SABR in Elderly NSCLC Patients, Study Finds

Phase I Trial Validates Safety of SABR for Extended Polymetastatic Cancer Treatment

Page 1 of 56